Q4 2028
Ends Dec 31, 2028
Revenue
$0.3B
$0.3B to $0.3B
EPS
0.27
0.27 to 0.27
No analyst count
EPS: No analyst count
Apr 28, 02:31 PM UTC
stable/analyst-estimates
Healthcare
Live Price
Offline$9.49
+0.85% today
Window Change
-49.30%
Window
Dec 11, 2025 → Jun 15, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 126 bars · Dec 11, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) is a fund with a market cap of $940.00M and listed on NASDAQ. The fund last traded around $9.49 and down 49.3% across the available one-year price window (Dec 11, 2025 → Jun 15, 2026). Valuation is more restrained than many high-expectation growth names at price/sales 1.8. Stock Foundry combines LMRI price history, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
LMRI
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
LMRI Max Drawdown
-63.46%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for LMRI and SPY.
EPS Consensus
0.27
Range 0.27 → 0.27
No analyst count
vs prior: +8.0%Revenue Outlook
$0.3B
Range $0.3B → $0.3B
No analyst count
vs prior: +2.8%Consensus Spread
Lower spread suggests tighter agreement across covering analysts.
Trend
Consensus average across visible periods
Trend
Average analyst revenue estimate
Timeline
Sorted by period end date. Includes both cached rows and live fallbacks from FMP.
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.